| Size & multiples | |||
| Market Cap | NOK 3.7M | Enterprise Value | — |
| P/E (TTM) | — | PEG (trailing) | — |
| P/S | 0.38× | P/FCF | — |
| EV/EBITDA | — | EV/EBIT | — |
| EV/Sales | — | EV/FCF | — |
| FCF Yield | −2134.01% | Buyback Yield | 1.44% |
| Owner Earnings (TTM) | -NOK 71.8M | Owner Earnings Yield | −1955.63% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | −1.41 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | −3.05% |
| After-tax Cost of Debt | — | WACC | — |
| ROIC | — | EVA Spread (ROIC−WACC) | — |
| EVA | — | ||
Flows latest annual · EPS TTM -NOK 5.73 · revenue TTM NOK 9.7M · FCF TTM -NOK 78.3M (in NOK)
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| FCF Yield | -2134.0% | -7.8% | -34.7%–1.4% | 1 ↓weak |
| Net Margin | -742.0% | -21.2% | -325.3%–7.2% | 18 ↓weak |
| Operating Margin | -876.7% | -34.5% | -552.0%–8.0% | 21 ↓weak |
| ROE | -102.2% | -36.8% | -92.5%–4.5% | 22 ↓weak |
